| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 5.94 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Com o surto de pandemia por COVID-19 a levantar constantes desafios a empresas e
colaboradores, é pertinente questionarmos se existiu um impacto nas práticas de
responsabilidade social corporativa, mais especificamente nos colaboradores.
Assim, foi investigado o impacto das práticas de RSC da indústria farmacêutica em
Portugal no envolvimento de colaboradores no contexto da pandemia por COVID-19. Após
um enquadramento teórico de noções pertinentes para o tema em estudo, foi conduzido um
estudo com recurso a análise de conteúdo proveniente de relatórios de RSC ou websites e de
entrevistas a colaboradores de quatro empresas da indústria farmacêutica presentes em
Portugal.
Devido à pandemia por COVID-19 a indústria farmacêutica em Portugal adaptou as suas
práticas de responsabilidade social corporativa. Esta adaptação não terá sido
necessariamente através da criação de práticas para fazer face aos efeitos da pandemia,
traduzindo-se antes numa adaptação de práticas existentes que possibilitem a realização em
contexto pandémico de ações de responsabilidade social corporativa previamente definidas.
Ao nível dos colaboradores, esta adaptação de práticas traduziu-se sobretudo na
adaptação das empresas aos novos desafios ao bem-estar do colaborador que o modelo de
trabalho remoto trouxe consigo. Contudo, estes esforços desenvolvidos no sentido de ser um
empregador responsável nem sempre são acompanhados por um aumento no leque de ações.
Concluindo, embora não seja possível afirmar que a alteração de práticas de
responsabilidade social corporativa teve impacto no envolvimento de colaboradores, a
presente dissertação fornece pistas sobre esta relação no contexto da pandemia por COVID19.
With the outbreak of the COVID-19 pandemic raising constant challenges for companies and employees, it is pertinent to question whether there was an impact on corporate social responsibility practices, more specifically on employee engagement. Thus, we investigate the impact of CSR practices in the pharmaceutical industry in Portugal on the involvement of employees in the context of the COVID-19 pandemic. After a theoretical framework of relevant notions for the subject of research, a study was conducted using a content analysis from CSR reports, websites and interviews with employees of four pharmaceutical companies in Portugal. Due to the COVID-19 pandemic, the pharmaceutical industry in Portugal has adapted its corporate social responsibility practices. This alteration was not necessarily through the creation of practices to deal with the effects of the pandemic, but rather translated into an adaptation of existing practices that make it possible to carry out previously defined corporate social responsibility actions in a pandemic context. At the level of employees, this change in practices was mainly reflected in the adjustment of companies to the new challenges to the well-being of the employee that the remote work model brought with it. However, these efforts towards being a responsible employer are not always accompanied by an increase in the range of CSR actions. In conclusion, although it is not possible to say that the change in corporate social responsibility practices had an impact on employee engagement, the present study provides clues about this relationship in the context of the COVID-19 pandemic.
With the outbreak of the COVID-19 pandemic raising constant challenges for companies and employees, it is pertinent to question whether there was an impact on corporate social responsibility practices, more specifically on employee engagement. Thus, we investigate the impact of CSR practices in the pharmaceutical industry in Portugal on the involvement of employees in the context of the COVID-19 pandemic. After a theoretical framework of relevant notions for the subject of research, a study was conducted using a content analysis from CSR reports, websites and interviews with employees of four pharmaceutical companies in Portugal. Due to the COVID-19 pandemic, the pharmaceutical industry in Portugal has adapted its corporate social responsibility practices. This alteration was not necessarily through the creation of practices to deal with the effects of the pandemic, but rather translated into an adaptation of existing practices that make it possible to carry out previously defined corporate social responsibility actions in a pandemic context. At the level of employees, this change in practices was mainly reflected in the adjustment of companies to the new challenges to the well-being of the employee that the remote work model brought with it. However, these efforts towards being a responsible employer are not always accompanied by an increase in the range of CSR actions. In conclusion, although it is not possible to say that the change in corporate social responsibility practices had an impact on employee engagement, the present study provides clues about this relationship in the context of the COVID-19 pandemic.
Description
Keywords
Responsabilidade social corporativa Envolvimento de stakeholders Envolvimento de colaboradores Pandemia por COVID-19 Corporate social responsibility Stakeholder engagement Employee engagement COVID-19 pandemic